US Broker Ratings

Tvardi Therapeutics, Inc. (TVRD) Stock Analysis: Exploring a 115% Potential Upside in the Biotech Sector

In the ever-evolving landscape of biotechnology, Tvardi Therapeutics, Inc. (NASDAQ: TVRD) emerges as a promising player focusing on groundbreaking therapies for fibrosis-driven diseases. Based in Sugar..

Neuronetics, Inc. (STIM) Stock Analysis: Is the 388% Potential Upside Enough to Attract Investors?

Neuronetics, Inc. (NASDAQ: STIM) is a healthcare company that has been capturing attention with its pioneering approach in medical devices, specifically through its NeuroStar Advanced Therapy..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: Exploring a Potential 209% Upside

In the ever-evolving world of biotechnology, Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) stands out as a company with intriguing prospects, particularly for investors with a keen..

Viemed Healthcare, Inc. (VMD): Investor Outlook Reveals 43% Potential Upside in Respiratory Care Sector

Viemed Healthcare, Inc. (NASDAQ: VMD), a prominent player in the healthcare sector specializing in medical devices, is capturing the attention of investors with its robust revenue..

Outset Medical, Inc. (OM) Stock Analysis: Exploring a 197% Potential Upside in the Healthcare Sector

Outset Medical, Inc. (NASDAQ: OM) stands at the intersection of innovation and opportunity in the healthcare sector, particularly within the medical devices industry. As a company..

Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: Exploring a Potential 127% Upside

Investors looking into the biotechnology sector may find Fulcrum Therapeutics, Inc. (NASDAQ: FULC) an intriguing prospect, given its substantial potential upside of 127.54% based on current..

National Research Corporation (NRC) Investor Outlook: Evaluating High Dividend Yield Amidst Revenue Decline

National Research Corporation (NRC), a U.S.-based leader in health information services, offers investors a compelling mix of high dividend yield and challenges in revenue growth. With..

Benitec Biopharma Inc. (BNTC) Stock Analysis: Exploring a 118% Potential Upside

Investors with an eye on the biotechnology sector may find Benitec Biopharma Inc. (BNTC) an intriguing prospect, especially given its substantial potential upside of 118.45%. At..

Quantum-Si Incorporated (QSI): Investor Outlook on a Medical Device Innovator with 176% Potential Upside

Quantum-Si Incorporated (NASDAQ: QSI) presents a compelling case for investors seeking opportunities in the burgeoning field of medical devices, particularly in the innovative realm of Next..

Erasca, Inc. (ERAS) Stock Analysis: Navigating the Biotech Path with a Market Cap of $4.68 Billion

Erasca, Inc. (NASDAQ: ERAS) is making waves in the biotech sector with a market capitalization of $4.68 billion, catching the attention of investors eager to explore..

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: Unveiling a 72.8% Potential Upside

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) has emerged as a promising player in the biotechnology sector, captivating investors with its robust pipeline and strategic partnerships. With a..

ClearPoint Neuro Inc. (CLPT) Stock Analysis: Navigating a 168% Potential Upside in the Medical Devices Sector

ClearPoint Neuro Inc. (NASDAQ: CLPT) is capturing the attention of investors with its intriguing position in the healthcare sector, specifically within the medical devices industry. With..

Spok Holdings, Inc. (SPOK) Stock Analysis: A Closer Look at Its 10.20% Dividend Yield and 14.29% Potential Upside

Investors in the healthcare sector looking for steady income might find Spok Holdings, Inc. (NASDAQ: SPOK) an intriguing option, particularly given its robust dividend yield and..

TotalEnergies SE (TTE) Investor Outlook: Analyzing Potential and Performance with a 5.08% Dividend Yield

TotalEnergies SE (NYSE: TTE) is a formidable player in the energy sector, operating across a wide spectrum of energy sources, from traditional oil and gas to..

Nano-X Imaging Ltd (NNOX): Investor Outlook Highlights Stunning 179% Upside Potential

Nano-X Imaging Ltd (NASDAQ: NNOX), a pioneering company in the healthcare sector, is making waves with its promising potential upside, capturing the attention of both seasoned..

MiMedx Group, Inc (MDXG) Stock Analysis: A Biotech Powerhouse with Nearly 100% Upside Potential

MiMedx Group, Inc (MDXG), a key player in the biotechnology industry, stands at a compelling juncture for those eyeing promising investment opportunities in the healthcare sector...

Harrow, Inc. (HROW) Stock Analysis: A 31.79% Upside in the Healthcare Sector Beckons Investors

Harrow, Inc. (HROW) has been making waves in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of $1.98..

BioLife Solutions, Inc. (BLFS) Stock Analysis: 43.87% Potential Upside Captures Investor Attention

BioLife Solutions, Inc. (NASDAQ: BLFS) is making waves in the healthcare sector, particularly within the medical instruments and supplies industry. Known for its innovative contributions to..

NeoGenomics, Inc. (NEO) Stock Analysis: Exploring a 55.92% Potential Upside in the Diagnostics Sector

Investors seeking opportunities in the healthcare sector may find NeoGenomics, Inc. (NASDAQ: NEO) an intriguing prospect. As a prominent player in the diagnostics and research industry,..

Teladoc Health, Inc. (TDOC) Stock Analysis: A Look at the 41% Potential Upside for Investors

Teladoc Health, Inc. (NYSE: TDOC) stands as a prominent player in the rapidly evolving healthcare sector, specifically within the health information services industry. Headquartered in New..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds